Stay updated on TROPION-Lung07: Dato-DXd vs Pembrolizumab in 1L NSCLC Clinical Trial
Sign up to get notified when there's something new on the TROPION-Lung07: Dato-DXd vs Pembrolizumab in 1L NSCLC Clinical Trial page.

Latest updates to the TROPION-Lung07: Dato-DXd vs Pembrolizumab in 1L NSCLC Clinical Trial page
- Check2 days agoChange DetectedThe footer now shows Revision: v3.5.2, replacing the previous Revision: v3.5.0.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedAdded new study identifiers KEYNOTE-E10, MK-3475-E10, and jRCT2061220066; removed MK3475-C73 and updated the registry labeling.SummaryDifference0.1%

- Check38 days agoChange DetectedRevision: v3.4.3 was added, replacing v3.4.2 in the page's release notes.SummaryDifference0.0%

- Check53 days agoChange DetectedAdded detailed primary objectives (PFS/OS) and endpoint definitions (ORR, DoR, DCR, PFS, OS) along with TROP2 NMR assessment and IPD data-sharing information. Removed or altered several earlier endpoint definitions, time frames, and explicit eligibility criteria.SummaryDifference0.7%

- Check60 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed, a minor metadata update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page now shows Revision: v3.4.1 and the government funding notice and Revision: v3.4.0 have been removed.SummaryDifference0.1%

Stay in the know with updates to TROPION-Lung07: Dato-DXd vs Pembrolizumab in 1L NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TROPION-Lung07: Dato-DXd vs Pembrolizumab in 1L NSCLC Clinical Trial page.